British American Tobacco’s stock recovery signals investor confidence in its pivot away from traditional cigarettes. The company is betting heavily on nicotine pouches and vapes to replace declining combustible tobacco sales. This shift reflects a broader industry trend where legacy players are repositioning for an addictive future beyond smoke.

The move comes as global smoking rates fall and regulators crack down on flavored products. BAT’s strategy hinges on its vuse and velo brands gaining market share in the U.S. and Europe. Success here could stabilize revenues and justify higher valuations for a sector once considered stagnant.

Investors will watch BAT’s next earnings for growth metrics in these new categories. The company’s ability to defend market share against rivals like Philip Morris International’s IQOS is critical. A sustained recovery could cement BAT’s role as a nicotine delivery leader, reshaping the tobacco landscape.